Literature DB >> 3265942

Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

B A Claesson1, T Lagergård, B Trollfors.   

Abstract

The development of total immunoglobulin G (IgG) antibodies and antibodies of the four IgG subclasses in serum against Haemophilus influenzae type b capsular polysaccharide (CPS) was studied in 24 children and 11 adults with invasive Haemophilus influenzae type b infections, by using an enzyme-linked immunosorbent assay. None of the 8 children aged 10 months or younger had increases in the IgG class or in any of the IgG subclasses. In contrast, 14 of 16 children between 10 months and 6 years of age and 10 of 11 adults had significant increases in total IgG, IgG1, or IgG2 antibodies in various combinations, but none of them had increases in IgG3 or IgG4 antibodies. The increases in IgG1 and IgG2 antibodies in the children were of similar magnitudes. Of 11 adult patients, 9 had significant increases in IgG2 antibodies, while only 4 had increases in IgG1 antibodies. In conclusion, this study shows that children younger than approximately 1 year have no IgG response to H. influenzae type b CPS, while individuals above this age have a mixed IgG1 and IgG2 response.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265942      PMCID: PMC266943          DOI: 10.1128/jcm.26.12.2549-2553.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

Authors:  B A Claesson; B Trollfors; T Lagergard; J Taranger; D Bryla; G Otterman; T Cramton; Y Yang; C B Reimer; J B Robbins
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

Review 2.  Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.

Authors:  J B Robbins
Journal:  Immunochemistry       Date:  1978-11

3.  IgG subclass levels in infancy and childhood.

Authors:  V A Oxelius
Journal:  Acta Paediatr Scand       Date:  1979-01

4.  Quantification of IgG subclasses in sera of normal adults and healthy children between 4 and 12 years of age.

Authors:  M van der Giessen; E Rossouw; T A van Veen; E van Loghem; B J Zegers; P C Sander
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

5.  Immunoglobulin subclasses in normal children.

Authors:  P H Schur; F Rosen; M E Norman
Journal:  Pediatr Res       Date:  1979-03       Impact factor: 3.756

6.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Development of respiratory mucosal tolerance during Haemophilus influenzae type B infection in infancy.

Authors:  S V Rosales; L J Lascolea; P L Ogra
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

8.  Class-specific antibody response to Haemophilus influenzae type b capsular polysaccharide vaccine.

Authors:  H Käyhty; R Schneerson; A Sutton
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

9.  Enzyme-linked immunosorbent assay for detection of capsular antibodies against Haemophilus influenzae type b: comparison with radioimmunoassay.

Authors:  S L Kaplan; E O Mason; G Johnson; R A Broughton; D Hurley; J C Parke
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  2 in total

1.  Immunoglobulin G avidities in infants in Mexico after primary immunization with three doses of polyribosylribitol phosphate-tetanus toxoid Haemophilus influenzae type b vaccine.

Authors:  Patricia Gómez-de-León; F Javier Díaz-García; Alberto Villaseñor-Sierra; Jorge Segura; Martha I Carranza; José Luis Arredondo-Garcia; José Ignacio Santos
Journal:  Clin Vaccine Immunol       Date:  2008-04-16

2.  Subclass compositions of immunoglobulin G to pertussis toxin in patients with whooping cough, in healthy individuals, and in recipients of a pertussis toxoid vaccine.

Authors:  G Zackrisson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.